Disclosure Of Fair Value Measurement [Text Block]

Hyloris Pharmaceuticals SA - Filing #3166306

Concept As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
Disclosure of fair value measurement [text block]
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
63,444 EUR
69,182 EUR
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of liabilities [text block]
Disclosure of fair value measurement of liabilities [abstract]
Disclosure of fair value measurement of liabilities [line items]
Liabilities
15,388 EUR
10,123 EUR
Reconciliation of changes in fair value measurement, liabilities [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
54,805 EUR
476,000 EUR
48,056 EUR
3,827 EUR
103,693 EUR
2,391 EUR
129,000 EUR
43,226 EUR
129,000 EUR
3,827 EUR
476,000 EUR
1,814 EUR
103,693 EUR
59,059 EUR
493,000 EUR
23,982 EUR
10,188 EUR
36,081 EUR
1,329 EUR
89,000 EUR
- EUR
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.